NCT03325855 Fecal Microbiota Transplant National Registry
| NCT ID | NCT03325855 |
| Status | Recruiting |
| Phase | — |
| Sponsor | American Gastroenterological Association |
| Condition | Fecal Microbiota Transplantation |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2017-09-20 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2017-09-20 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness
Eligibility Criteria
Inclusion Criteria: * Recipient Inclusion Criteria * Ability to give informed consent * Receiving FMT or other gut-related microbiota product within 90 days after providing consent * Access to internet and/or telephone * Donor Inclusion * Ability to give informed consent * Providing stool sample for FMT Exclusion Criteria: * Incarceration
Contact & Investigator
Gary D Wu, MD
PRINCIPAL INVESTIGATOR
Co-Director, PennCHOP Microbiome Program
Frequently Asked Questions
Who can join the NCT03325855 clinical trial?
This trial is open to participants of all sexes, studying Fecal Microbiota Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03325855 currently recruiting?
Yes, NCT03325855 is actively recruiting participants. Contact the research team at sserra@gastro.org for enrollment information.
Where is the NCT03325855 trial being conducted?
This trial is being conducted at Phoenix, United States, Los Angeles, United States, Los Angeles, United States, Redwood City, United States and 11 additional locations.
Who is sponsoring the NCT03325855 clinical trial?
NCT03325855 is sponsored by American Gastroenterological Association. The principal investigator is Gary D Wu, MD at Co-Director, PennCHOP Microbiome Program. The trial plans to enroll 4,000 participants.